Berb-Evail
Natural health product licensed in Canada
- Other names
- Advanced CV & Lipid Health, Berberine Evail, Berberine Formula
- Licence holder
- Designs for Health
- NPN or DIN-HM
- 80077030
- Status
- Active licence
- Licence date
- 27 April 2017
- Revision date
- 27 April 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 5,6-Dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium Source : Berberis aristata- Racine | 400 milligramme | Not calculated |
| 5,6-Dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium Source : Berberine hydrochloride | 400 milligramme | Not calculated |
Non-medicinal ingredients
Lécithine, tocotriénols, Glycérine, Cire jaune, Eau, Gélatine, NA, Extrait de quillaya, Extrait de roucou
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to maintain/support cardiovascular health. Provides support for healthy lipid metabolism. Helps support healthy cholesterol levels (serum triglyceride, total, and LDL).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking other medications or natural health products. Consult a health care practitioner prior to use if you have hypoglycemia or hypotension. Consult a health care practitioner prior to use if you have a liver or kidney disorder, cardiovascular disease, diabetes or a blood disorder. If you have gall stones, consult a health care practitioner prior to use.
- Contre-indications
Do not use if you are pregnant or breastfeeding.
- Effets indésirables connus
Some people may experience skin irritation, facial flushing and slowed heart rate. May cause gastrointestinal discomfort such as constipation, vomiting, abdominal pain or diarrhea in which case discontinue use and consult a health care practitioner.
Source
Official Health Canada record, licence 80077030
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.